Tech Company Financing Transactions
OCON Therapeutics Funding Round
OCON Therapeutics closed a $10 million funding round on 6/24/2024. Investors included RH Capital, Astia Angel and Features Capital.
Transaction Overview
Company Name
Announced On
6/24/2024
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to further enhance its ability to provide solutions for treating prevalent uterine pathologies.
Company Information
Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
Hamiktso'ot Blvd. 14
Modiin, 7178095
Israel
Modiin, 7178095
Israel
Phone
Website
Email Address
Overview
OCON Therapeutics innovates, develops, manufactures, and commercializes cutting-edge women's health products based on our patented IUB® (Intra Uterine Ball) proprietary platform. The IUB® made from a super-elastic alloy Nitinol, is an ideal carrier for multiple drugs to the uterus to treat a variety of conditions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Anula Jayasuriya
Chief Executive Officer
Keren Leshem
Chief Financial Officer
Amir Avraham
Chief Medical Officer
Sergio Haimovich
VP - Marketing
Daniela Schardinger
VP - Operations
Rachel Safra-Zafrany
VP - Operations
Daniel Sclar
VP - Regulatory Affairs
Adely Levy
VP - Sales
Susanne Mair
Browse more venture capital transactions:
Prev: 6/24/2024: Skynopy venture capital transaction
Next: 6/25/2024: Freyja Healthcare venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We record tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs